Rpigat 2.5mg Tablet
Marketer
Natco Pharma Ltd
Salt Composition
Rivaroxaban (2.5mg)
Overview Rpigat 2.5mg Tablet
CardioGuard 2.5mg tablets function as an anticoagulant, preventing and treating blood clots. This medication lowers the risk of stroke and heart attack by inhibiting clot formation in leg, lung, brain, and heart veins. Frequently prescribed for patients with atrial fibrillation to prevent clot formation, CardioGuard 2.5mg is also used post-knee or hip replacement surgery to minimize clotting risks. It can be taken with or without food, consistently at the same time daily for optimal efficacy. Long-term use, potentially lifelong, may be necessary. Discontinuing or altering dosage without physician consultation significantly increases the risk of stroke, heart attack, or thrombosis. Lifestyle modifications, including a healthy diet, exercise, weight management, and smoking cessation, further reduce clot risk. Increased bleeding (nosebleeds, bruising) is a common side effect; report any symptoms immediately. Contraindicated in individuals with severe liver or kidney disease, active bleeding, or concurrent use of other anticoagulants. Breastfeeding is not advised during treatment. Unlike some anticoagulants, routine PT-INR blood monitoring is unnecessary.
Primary Ingredients of Rpigat 2.5mg Tablet
No information provided. Please provide the text you wish me to rephrase.
Uses of Rpigat 2.5mg Tablet
Managing and averting blood clot formation.
Major Benefits of Rpigat 2.5mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The 2.5mg Rpigat tablet can be consumed with or without food, although consistent timing is recommended for optimal results.
Common Side effects of Rpigat 2.5mg Tablet:
- Bleeding
How to use Rpigat 2.5mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The 2.5mg Rpigat Tablet can be consumed with or without food, though consistent timing is recommended.
How Rpigat 2.5mg Tablet works:
Xafactor 2.5mg tablets are a new type of oral blood thinner. They inhibit the action of factor Xa, a clotting protein, thereby reducing the risk of blood clot development.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when combining alcoholic beverages and Rpigat 2.5mg Tablets. Physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
The use of Rpigat 2.5mg Tablet during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a fetus. A physician will assess the advantages against potential hazards prior to prescription. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
Use of Rpigat 2.5mg Tablet while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Driving ability may be impaired by Rpigat 2.5mg Tablet, which can induce dizziness or fainting. Side effects from Rpigat 2.5mg Tablet may compromise driving safety.
KidneyCAUTION
Patients with kidney impairment should use Rpigat 2.5mg tablets cautiously, potentially requiring dosage modification. Consult a physician before use. Rpigat 2.5mg tablets are contraindicated in patients with severe kidney disease.
LiverUNSAFE
The use of Rpigat 2.5mg tablets is likely inadvisable for individuals with hepatic impairment and should be avoided. Medical advice is recommended.
What if you forget to take Rpigat 2.5mg Tablet :
Should you forget a dose of Rpigat 2.5mg Tablet, take it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Rpigat 2.5mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Morpholine- and thiophene-based derivatives |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Behavioral Class | Factor Xa Inhibitors (Oral) |



